Patients with treatment-resistant cancer can now receive treatment with the myxoma virus in combination with immunotherapy.
Highlights:
A combination of two therapies has shown promising results for treating drug-resistant cancers, revealed a new study.
The immune system defends the body against various disease-associated challenges. It includes viral infections like the flu, the Ebola virus and SARS CoV-2, and bacterial diseases like the plague, cholera, diphtheria and Lyme disease. - Immunotherapy and virotherapy are used for treating certain malignancies
- A new strategy combining immunotherapy and virotherapy has shown significant success in treating certain drug-resistant cancers
About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
‘There is enormous potential in combining virotherapy with immunotherapy to treat drug-resistant cancers.’
Despite the immune system’s capabilities, one kind of threat is difficult to eliminate: Cancer. Cancer develops when the body’s cells go awry. The immune system constantly tries to clear the body of cancerous cells., but when the disease grows unchecked, its efforts are typically thwarted. Combination of Immunotherapy and Virotherapy in Treatment-Resistant Cancer
Myxoma virus, in combination with immunotherapy, gives patients with treatment-resistant cancer fresh hope.The strategy combines two therapies that have each had significant success in treating certain malignancies. Oncolytic virotherapy, a method that employs cancer-fighting viruses, can work in conjunction with the currently used immunotherapy. This approach enhances the immune system’s capability to target and eradicate cancer cells.
How to Cope with Cancer Pain - Caues, Types & Treatment
Pain occurs in about 20-50% of patients with cancer. Proper therapeutic approach can help relieve and manage the condition.
Pain occurs in about 20-50% of patients with cancer. Proper therapeutic approach can help relieve and manage the condition.
Treating Cancer with Oncolytic Viruses
An intriguing new approach to treating cancer is using oncolytic viruses. Such viruses increase the immune system’s capacity to identify and eliminate cancer cells. They also have the unique ability to seek and destroy cancer cells while sparing healthy cells.Myxoma, one of these viruses, is the subject of the present study and a specialty for the research team. Using T-cells infected with the myxoma virus can cause a brand-new type of cancer cell death.
Advertisement
About Pre Cancerous Lesions
Encyclopedia section of medindia gives general information about Pre Cancerous Lesions
Encyclopedia section of medindia gives general information about Pre Cancerous Lesions
“This work affirms the enormous potential of combining virotherapy with cell therapy to treat currently intractable cancers,” said McFadden, author of the study.
Advertisement
Hair Dyes and Cancer Risk - Types, Chemicals, Side Effects, Precautionary Methods
There is no definite evidence that the currently used hair dyes are associated with cancer risk.
There is no definite evidence that the currently used hair dyes are associated with cancer risk.
